On Monday, Health Catalyst Inc (NASDAQ: HCAT) was 6.79% up from the session before settling in for the closing price of $3.24. A 52-week range for HCAT has been $2.52 – $9.24.
During the last 5-year period, the sales growth of Healthcare Sector giant was 38.24%. When this article was written, the company’s average yearly earnings per share was at -21.34%. With a float of $65.97 million, this company’s outstanding shares have now reached $70.27 million.
Health Catalyst Inc (HCAT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Health Catalyst Inc stocks. The insider ownership of Health Catalyst Inc is 6.26%, while institutional ownership is 77.94%. The most recent insider transaction that took place on Sep 05 ’25, was worth 20,705. In this transaction General Counsel of this company sold 6,175 shares at a rate of $3.35, taking the stock ownership to the 141,812 shares. Before that another transaction happened on Sep 05 ’25, when Company’s Officer proposed sale 6,175 for $3.30, making the entire transaction worth $20,378.
Health Catalyst Inc (HCAT) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.07 earnings per share (EPS) during the time that was less than consensus figure (set at 0.09) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -21.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.45% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
You can see what Health Catalyst Inc (HCAT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.42 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Looking closely at Health Catalyst Inc (NASDAQ: HCAT), its last 5-days average volume was 0.46 million, which is a drop from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 88.27%.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 53.22%, which indicates a significant decrease from 97.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was lower than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.08, while its 200-day Moving Average is $4.00. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $3.57. Second resistance stands at $3.68. The third major resistance level sits at $3.87. If the price goes on to break the first support level at $3.27, it is likely to go to the next support level at $3.08. Now, if the price goes above the second support level, the third support stands at $2.97.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
There are 70,374K outstanding shares of the company, which has a market capitalization of 243.49 million. As of now, sales total 306,580 K while income totals -69,500 K. Its latest quarter income was 80,720 K while its last quarter net income were -40,980 K.
